Celmatix study shows women may be stopping IVF treatment prematurely
A recent study by Celmatix Inc. suggests that women may be stopping IVF treatment prematurely, with 68% conceiving within two cycles and over half (60%) becoming pregnant if they proceeded with an additional two cycles. The study also explored genetic markers for female infertility and IVF success.